The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Stimulation of γδ T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma
Abstract
Bisphosphonates are well-known inhibitors of osteoclastic bone resorption, but recent clinical reports support the possibility of direct or indirect antitumor effects by these compounds. Because bisphosphonates share structural homologies with recently identified γδ T-cell ligands, we examined the stimulatory capacity of bisphosphonates to γδ T cells and determined whether γδ T-cell stimulation by bisphosphonates could be exploited to generate antiplasma cell activity in multiple myeloma (MM). All tested aminobisphosphonates (alendronate, ibandronate, and pamidronate) induced significant expansion of γδ T cells (Vγ9Vδ2 subset) in peripheral blood mononuclear cell cultures of healthy donors at clinically relevant concentrations (half-maximal activity, 0.9-4 μmol/L). The proliferative response of γδ T cells to aminobisphosphonates was IL-2 dependent, whereas activation of γδ T cells (up-regulation of CD25 and CD69) occurred in the absence of exogenous cytokines. Pamidronate-activated γδ T cells produced cytokines (ie, interferon [IFN]-γ) and exhibited specific cytotoxicity against lymphoma (Daudi) and myeloma cell lines (RPMI 8226, U266). Pamidronate-treated bone marrow (BM) cultures of 24 patients with MM showed significantly reduced plasma cell survival compared with untreated cultures, especially in cultures in which activation of BM-γδ T cells was evident (14 of 24 patients with MM). γδ T-cell depletion from BM cultures completely abrogated the cytoreductive effect on myeloma cells in 2 of 3 tested patients with MM. These results show that aminobisphosphonates stimulating γδ T cells have pronounced effects on the immune system, which might contribute to the antitumor effects of these drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Luckman, S. P., Hughes, D. E., Coxon, F. P., Russell, R. G. G., & Dr. Rogers, M. J. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.4.581 · Cited by 1,176
Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma
Berenson, J. R., Lichtenstein, A., Porter, L., Dimopoulos, M. A., Bordoni, R., George, S., Lipton, A., Keller, A., Ballester, O., Kovacs, M. J., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602223340802 · Cited by 1,081
Natural and synthetic non-peptide antigens recognized by human γδ T cells
Tanaka, Y., Morita, C. T., Tanaka, Y., Nieves, E., Brenner, M. B., & Bloom, B. R. (1995) · Nature · doi:10.1038/375155a0 · Cited by 1,013
Sato, M., Grasser, W., Endo, N., Akins, R., Simmons, H., Thompson, D. D., Golub, E., & Rodan, G. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115539 · Cited by 1,004
Bisphosphonates: mechanisms of action.
Rodan, G. A., & Fleisch, H. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118722 · Cited by 921
Haas, W., Pereira, P., & Tonegawa, S. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.003225 · Cited by 807
Stimulation of Human γδ T Cells by Nonpeptidic Mycobacterial Ligands
Constant, P., Davodeau, F., Peyrat, M.-A., Poquet, Y., Puzo, G., Bonneville, M., & Fournié, J.-J. (1994) · Science · doi:10.1126/science.8146660 · Cited by 711
Fisher, J. E., Rogers, M. J., Halasy, J. M., Luckman, S. P., Hughes, D. E., Masarachia, P. J., Wesolowski, G., Russell, R. G. G., Rodan, G. A., & Reszka, A. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.133 · Cited by 676
Berenson, J. R., Lichtenstein, A., Porter, L., Dimopoulos, M. A., Bordoni, R., George, S., Lipton, A., Keller, A., Ballester, O., Kovacs, M., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.593 · Cited by 648
Frith, J. C., Mönkkönen, J., Blackburn, G. M., Russell, R. G. G., & Rogers, M. J. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.9.1358 · Cited by 437
Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice.
Sasaki, A., Boyce, B. F., Story, B. M., Wright, K. R., Chapman, M., Boyce, R. W., Mundy, G. R., & Yoneda, T. (1995) · PubMed · Cited by 417
Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti‐tumour activity
Shipman, C. M., Rogers, M. J., Apperley, J. F., Russell, R. G. G., & Croucher, P. I. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.2713086.x · Cited by 398
γ/δ T-Cell Stimulation by Pamidronate
Kunzmann, V., Bauer, E., & Wilhelm, M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903043400914 · Cited by 395
Self-citationNonpeptide ligands for human gamma delta T cells.
Tanaka, Y., Sano, S., Nieves, E., De Libero, G., Rosa, D., Modlin, R. L., Brenner, M. B., Bloom, B. R., & Morita, C. T. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.17.8175 · Cited by 373
Recognition by Human V γ 9/V δ 2 T Cells of a GroEL Homolog on Daudi Burkitt's Lymphoma Cells
Fisch, P., Malkovsky, M., Kovats, S., Sturm, E., Braakman, E., Klein, B. S., Voss, S. D., Morrissey, L. W., DeMars, R., Welch, W. J., et al. (1990) · Science · doi:10.1126/science.1978758 · Cited by 358
A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma
McCloskey, MacLennan, Drayson, Chapman, Dunn, Kanis, & Adults, F. T. M. W. P. O. L. I. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00567.x · Cited by 314
Bukowski, J. F., Morita, C. T., Tanaka, Y., Bloom, B. R., Brenner, M. B., & Band, H. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.3.998 · Cited by 276
In vitro cytoreductive effects on multiple myeloma cells induced by bisphosphonates
Aparicio, A., Gardner, A., Tu, Y., Savage, A., Berenson, J., & Lichtenstein, A. (1998) · Leukemia · doi:10.1038/sj.leu.2400892 · Cited by 259
Transfer of myeloma idiotype-specific immunity from an actively immunised marrow donor
Kwak, L. W., Duffey, P. L., Reynolds, C. W., Longo, D. L., Taub, D. D., Bensinger, W. I., & Bryant, E. M. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90757-2 · Cited by 256
Shipman, C. M., Croucher, P. I., Russell, R. G. G., Helfrich, M. H., & Rogers, M. J. (1998) · PubMed · Cited by 216
Thiébaud, D., Sauty, A., Burckhardt, P., Leuenberger, P., Sitzler, L., Green, J. R., Kandra, A., Zieschang, J., & Palacios, P. I. D. (1997) · Calcified Tissue International · doi:10.1007/s002239900353 · Cited by 206
Sauty, A., Pecherstorfer, M., Zimmer-Roth, I., Fioroni, P., Juillerat, L., Markert, M., Ludwig, H., Leuenberger, P., Burckhardt, P., & Thiébaudi, D. (1996) · Bone · doi:10.1016/8756-3282(95)00448-3 · Cited by 176
Bürk, M. R., Mori, L., & de Libero, G. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250737 · Cited by 160
Lamb, L. S., Henslee‐Downey, P. J., Parrish, R. S., Godder, K. T., THOMPSON, J. S., Lee, C. G., & Gee, A. P. (1996) · Journal of Hematotherapy · doi:10.1089/scd.1.1996.5.503 · Cited by 149
Haas, W. (1993) · Annual Review of Immunology · doi:10.1146/annurev.immunol.11.1.637 · Cited by 141
Bukowski, J. F., Morita, C. T., Band, H., & Brenner, M. B. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.1.286 · Cited by 125
Bisphosphonates inhibit IL-6 production by human osteoblast-like cells
Giuliani, N. (1998) · Scandinavian Journal of Rheumatology · doi:10.1080/030097498441155 · Cited by 121
Bukowski, J. F., Morita, C. T., Band, H., et al. (1998) · PubMed · Cited by 118
Functionally distinct subsets of human γ/δ T cells
Morita, C. T., Verma, S., Aparício, P., Martínez‐A, C., Spits, H., & Brenner, M. B. (1991) · European Journal of Immunology · doi:10.1002/eji.1830211215 · Cited by 109
Anti‐myeloma activity of pamidronate in vivo
Dhodapkar, M. V., Singh, J., Mehta, J., Fassas, A., Desikan, Perlman, M., Munshi, N. C., & Barlogie, B. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00976.x · Cited by 104
Portier, M., Zhang, X., Caron, E., Lu, Z., Bataille, R., & Klein, B. (1993) · Blood · doi:10.1182/blood.v81.11.3076.3076 · Cited by 79
Spets, H., Georgii‐Hemming, P., Siljason, J., Nilsson, K., & Jernberg‐Wiklund, H. (1998) · Blood · doi:10.1182/blood.v92.8.2914 · Cited by 76
Massaia, M., Attisano, C., Peola, S., Montacchini, L., Omedè, P., Corradini, P., Ferrero, D., Boccadoro, M., Bianchi, A., & Pileri, A. (1993) · Blood · doi:10.1182/blood.v82.6.1787.1787 · Cited by 36
Cited by
Systematic Review: Bisphosphonates and Osteonecrosis of the Jaws
Woo, S.-B., Hellstein, J. W., & Kalmar, J. R. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-10-200605160-00009 · Cited by 1,252
Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer
Gnant, M., Mlineritsch, B., Schippinger, W., Luschin-Ebengreuth, G., Pöstlberger, S., Menzel, C., Jakesz, R., Seifert, M., Hubalek, M., Bjelic-Radisic, V., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806285 · Cited by 1,025
Davies, F. E., Raje, N., Hideshima, T., Lentzsch, S., Young, G., Tai, Y.-T., Lin, B., Podar, K., Gupta, D., Chauhan, D., et al. (2001) · Blood · doi:10.1182/blood.v98.1.210 · Cited by 913
Human T Cell Receptor γδ Cells Recognize Endogenous Mevalonate Metabolites in Tumor Cells
Gober, H.-J., Kistowska, M., Angman, L., Jenö, P., Mori, L., & De Libero, G. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021500 · Cited by 847
Molecular Mechanisms of Action of Bisphosphonates: Current Status
Roelofs, A. J., Thompson, K., Gordon, S., & Rogers, M. J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0843 · Cited by 568
Metadata
- Authors
- Kunzmann, V., Bauer, E., Feurle, J., Tony, F. W., & Wilhelm, M.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2000-07-15
- Volume
- 96
- Issue
- 2
- Pages
- 384-392
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W60551495
- Cited by
- 669
- References
- 33
- FWCI
- 16.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.